Pure Red-Cell Aplasia Secondary to Antierythropoietin Antibodies [7]

New England Journal of Medicine

Volumn 349, Issue 26, 2003, Pages 2572-2573

  Guest, Steven S ^a   Levitt, Lee ^b  

^a SANTA CLARA VALLEY MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; ERYTHROPOIETIN ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G4; NEUTRALIZING ANTIBODY; RECOMBINANT ERYTHROPOIETIN; UNCLASSIFIED DRUG;

AGED; ANEMIA; ANIMAL CELL; CASE REPORT; CHRONIC KIDNEY FAILURE; FEMALE; HEMATOCRIT; HUMAN; LETTER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PURE RED CELL ANEMIA;

AGED; ANEMIA; AUTOANTIBODIES; DIAGNOSIS, DIFFERENTIAL; EPOETIN ALFA; ERYTHROPOIETIN; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; RED-CELL APLASIA, PURE;

EID: 0346256838     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200312253492623     Document Type: Letter

References (2)

1. Casadevall N, Nataf J, Viron B, et al. Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. N Engl J Med 2002;346:469-75.
2. Eckardt K, Casadevall N. Pure red-cell aplasia due to anti-erythropoietin antibodies. Nephrol Dial Transplant 2003;18:865-9.